Key result
Late presentation in AMI and DM linked to ~51% higher three-year mortality vs early presentation.
Why the study?
Real-world evidence regarding the association between time to presentation and outcomes following acute myocardial infarction and diabetes was limited.
Does late presentation increase mortality in patients with diabetes and acute myocardial infarction?
Observational (n=4,455)
Yes
Does late presentation increase mortality in patients with diabetes and acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Late hospital presentation in diabetic patients with acute myocardial infarction is associated with increased long-term all-cause mortality, highlighting the critical need to reduce pre-hospital delays.
BACKGROUND/AIMS: Due to limited real-world evidence on the association between time to presentation (T2P) and outcomes following acute myocardial infarction and diabetes (AMI-DM), we investigated the characteristics of patients with AMI-DM and their outcomes based on their T2P. METHODS: 4,455 patients with AMI-DM from a Korean nationwide observational cohort (2011-2015) were divided into early and late presenters according to symptom-to-door time. The effects of T2P on three-year all-cause mortality were estimated using inverse probability of treatment weighting (IPTW) and survival analysis. RESULTS: The incidence of all-cause mortality was consistently higher in late presenters than in early presenters (11.4 vs. 17.2%; p < 0.001). In the IPTW-adjusted dataset, the incidence of all-cause mortality was numerically higher in late presenters than in early presenters (9.1 vs. 12.4%; p = 0.072). In the survival analysis, the cumulative incidence of all-cause mortality was significantly higher in late presenters than in early presenters before and after IPTW. In the subgroup with ST-elevation myocardial infarction, late presenters had a higher incidence of cardiac death than early presenters before (4.8 vs. 10.5%; p < 0.001) and after IPTW (4.2 vs. 9.7%; p = 0.034). In the initial glycated hemoglobin (HbA1c)-stratified analysis, these effects were attenuated in patients with HbA1c ≥ 9.0% before (adjusted hazard ratio [HR]: 1.45, 95% confidence interval [CI]: 0.80-2.64) and after IPTW (adjusted HR: 0.82, 95% CI: 0.40-1.67). CONCLUSION: Late presentation was associated with higher mortality in patients with AMI-DM; therefore, multifaceted and systematic interventions are needed to decrease pre-hospital delays.
No takes yet. Share an insight, caveat, or question.
Shin et al. (2023) conducted an observational in Acute myocardial infarction with diabetes mellitus (n=4,455). Late presentation vs. Early presentation was evaluated on Three-year all-cause mortality (p=<0.001). Late presentation increased three-year all-cause mortality compared to early presentation in patients with acute myocardial infarction and diabetes mellitus.
Synapse has enriched 10 related papers. Consider them for comparative context: